After the death of a 60-year-old woman in the Netherlands who died after receiving the AstraZeneca (AZ) New Crown vaccine, the Ministry of Health announced on the 2nd that vaccination against AZ will be suspended for people under 60. Seven people have died of blood clots after receiving the AstraZeneca vaccine in the United Kingdom.
Lareb, the Dutch unit responsible for tracking drug side effects, said earlier Friday that it had received five adverse events of blood clots combined with low platelets, which occurred seven to 10 days after the AZ vaccine was administered, and that “the patients were all women aged 25 to 65 years, three had extensive pulmonary embolism, one woman died and one had a brain hemorrhage “.
The Dutch state news agency reported that about 10,000 people who had been scheduled to receive the injection have now been cancelled due to this decision by the Ministry of Health.
According to the Dutch Ministry of Health, the suspension will last until the 7th, when the European Medicines Agency (EMA) is expected to issue updated recommendations. Germany also took a similar decision earlier this week.
In the Netherlands, about 1.2 million people have been diagnosed with the new coronavirus so far, and more than 16,500 people have died of the disease.
The AZ vaccine developed by AstraZeneca has been reported to have caused bleeding, blood clots and low platelet counts after vaccination.
Germany, France, Italy and other largest member states of the European Union suspended the use of AZ vaccine on March 15, pending the findings of the EU medical regulatory unit. Sweden and Latvia also followed suit on March 16.
But experts warned that this move would pose a greater public health risk. France said it hopes European medical experts can figure out the safety of the AstraZeneca vaccine on March 18.
The European Medicines Agency (EMA) said on March 1 that experts investigating the association of the AstraZeneca vaccine with blood clots have so far found no specific risk factors, including age, but are investigating further.
The use of AstraZeneca’s new crown vaccine was suspended in several countries after it raised concerns about blood clots. But the European Medicines Agency (EMA) had previously said that the safety of AstraZeneca’s vaccine outweighed the risks.
The EMA also said its safety committee is expected to issue an updated recommendation on the AstraZeneca vaccine after its monthly meeting next week.
Recent Comments